177 related articles for article (PubMed ID: 38185226)
1. Microbiome metabolite quantification methods enabling insights into human health and disease.
Roach J; Mital R; Haffner JJ; Colwell N; Coats R; Palacios HM; Liu Z; Godinho JLP; Ness M; Peramuna T; McCall LI
Methods; 2024 Feb; 222():81-99. PubMed ID: 38185226
[TBL] [Abstract][Full Text] [Related]
2. Gut Microbial Metabolites and Blood Pressure Regulation: Focus on SCFAs and TMAO.
Poll BG; Cheema MU; Pluznick JL
Physiology (Bethesda); 2020 Jul; 35(4):275-284. PubMed ID: 32490748
[TBL] [Abstract][Full Text] [Related]
3. Short chain fatty acids and methylamines produced by gut microbiota as mediators and markers in the circulatory system.
Onyszkiewicz M; Jaworska K; Ufnal M
Exp Biol Med (Maywood); 2020 Jan; 245(2):166-175. PubMed ID: 31948289
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous HS-SPME GC-MS determination of short chain fatty acids, trimethylamine and trimethylamine N-oxide for gut microbiota metabolic profile.
Fiori J; Turroni S; Candela M; Brigidi P; Gotti R
Talanta; 2018 Nov; 189():573-578. PubMed ID: 30086962
[TBL] [Abstract][Full Text] [Related]
5. Interaction between gut microbiome and cardiovascular disease.
Peng J; Xiao X; Hu M; Zhang X
Life Sci; 2018 Dec; 214():153-157. PubMed ID: 30385177
[TBL] [Abstract][Full Text] [Related]
6. Gut Microbiota and Cardiovascular Disease.
Witkowski M; Weeks TL; Hazen SL
Circ Res; 2020 Jul; 127(4):553-570. PubMed ID: 32762536
[TBL] [Abstract][Full Text] [Related]
7. Gut microbiota-derived metabolites as central regulators in metabolic disorders.
Agus A; Clément K; Sokol H
Gut; 2021 Jun; 70(6):1174-1182. PubMed ID: 33272977
[TBL] [Abstract][Full Text] [Related]
8. Targeting on Gut Microbial Metabolite Trimethylamine-N-Oxide and Short-Chain Fatty Acid to Prevent Maternal High-Fructose-Diet-Induced Developmental Programming of Hypertension in Adult Male Offspring.
Hsu CN; Chang-Chien GP; Lin S; Hou CY; Tain YL
Mol Nutr Food Res; 2019 Sep; 63(18):e1900073. PubMed ID: 31295767
[TBL] [Abstract][Full Text] [Related]
9. Gut Microbiota in Hypertension and Atherosclerosis: A Review.
Verhaar BJH; Prodan A; Nieuwdorp M; Muller M
Nutrients; 2020 Sep; 12(10):. PubMed ID: 33003455
[TBL] [Abstract][Full Text] [Related]
10. Understanding connections and roles of gut microbiome in cardiovascular diseases.
Rajendiran E; Ramadass B; Ramprasath V
Can J Microbiol; 2021 Feb; 67(2):101-111. PubMed ID: 33079568
[TBL] [Abstract][Full Text] [Related]
11. The Role of Gut Microbiota and Trimethylamine N-oxide in Cardiovascular Diseases.
Huang Y; Zhang H; Fan X; Wang J; Yin Y; Zhang Y; Shi K; Yu F
J Cardiovasc Transl Res; 2023 Jun; 16(3):581-589. PubMed ID: 36251229
[TBL] [Abstract][Full Text] [Related]
12. Not a "they" but a "we": The microbiome helps promote our well-being.
Ragsdale SW
J Biol Chem; 2022 Feb; 298(2):101511. PubMed ID: 34929162
[TBL] [Abstract][Full Text] [Related]
13. Gut Microbiota and Atherosclerosis.
Li DY; Tang WHW
Curr Atheroscler Rep; 2017 Aug; 19(10):39. PubMed ID: 28842845
[TBL] [Abstract][Full Text] [Related]
14. Bacterial Metabolites: A Link between Gut Microbiota and Dermatological Diseases.
Stec A; Sikora M; Maciejewska M; Paralusz-Stec K; Michalska M; Sikorska E; Rudnicka L
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834904
[TBL] [Abstract][Full Text] [Related]
15. The microbiome and its pharmacological targets: therapeutic avenues in cardiometabolic diseases.
Neves AL; Chilloux J; Sarafian MH; Rahim MB; Boulangé CL; Dumas ME
Curr Opin Pharmacol; 2015 Dec; 25():36-44. PubMed ID: 26531326
[TBL] [Abstract][Full Text] [Related]
16. Microbial metabolites in non-alcoholic fatty liver disease.
Zhou D; Fan JG
World J Gastroenterol; 2019 May; 25(17):2019-2028. PubMed ID: 31114130
[TBL] [Abstract][Full Text] [Related]
17. The Gut Microbial Endocrine Organ in Type 2 Diabetes.
Massey W; Brown JM
Endocrinology; 2021 Feb; 162(2):. PubMed ID: 33373432
[TBL] [Abstract][Full Text] [Related]
18. Applying mass spectrometry-based assays to explore gut microbial metabolism and associations with disease.
Heaney LM
Clin Chem Lab Med; 2020 Apr; 58(5):719-732. PubMed ID: 31639103
[TBL] [Abstract][Full Text] [Related]
19. Interactions between polysaccharides and gut microbiota: A metabolomic and microbial review.
Zhang D; Liu J; Cheng H; Wang H; Tan Y; Feng W; Peng C
Food Res Int; 2022 Oct; 160():111653. PubMed ID: 36076442
[TBL] [Abstract][Full Text] [Related]
20. Contributory Role of Gut Microbiota and Their Metabolites Toward Cardiovascular Complications in Chronic Kidney Disease.
Li DY; Tang WHW
Semin Nephrol; 2018 Mar; 38(2):193-205. PubMed ID: 29602401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
